ST Pharm Co.Ltd (237690) — Cash Flow Quality Index
ST Pharm Co.Ltd (237690) has a Cash Flow Quality Index of -0.68x as of December 2025. Operating cash flow of ₩-21.16 Billion is below net income of ₩30.95 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore ST Pharm Co.Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ST Pharm Co.Ltd Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for ST Pharm Co.Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ST Pharm Co.Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for ST Pharm Co.Ltd (2015–2025)
Year-by-year earnings quality comparison for ST Pharm Co.Ltd. For live market cap and the full company financial profile, see ST Pharm Co.Ltd stock valuation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | ₩13.99 Billion | ₩54.99 Billion | ▼ -94.4% |
| 2024 | 4.56x | ₩109.45 Billion | ₩24.02 Billion | ▲ +6049.4% |
| 2023 | 0.07x | ₩1.30 Billion | ₩17.52 Billion | ▼ -80.1% |
| 2022 | 0.37x | ₩7.03 Billion | ₩18.85 Billion | ▼ -75.8% |
| 2021 | 1.54x | ₩7.27 Billion | ₩4.71 Billion | ▲ +27.5% |
| 2017 | 1.21x | ₩54.44 Billion | ₩45.00 Billion | ▲ +46.4% |
| 2016 | 0.83x | ₩50.78 Billion | ₩61.43 Billion | ▼ -41.9% |
| 2015 | 1.42x | ₩35.82 Billion | ₩25.19 Billion | — |